Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Andrew Thomas takes up UK comms agency role

Joins London-based Red Door Communications as head of international

Red Door Communications Pfizer Andrew ThomasPfizer's Andrew Thomas has moved agency-side to take up the role of head of international at London-based healthcare agency Red Door Communications.

Prior to joining the Creston Health Group agency he served at Pfizer as strategic communications lead for primary care medicines across Europe and Canada.

During this time, he handled a portfolio that included many of the company's highest profile medicines and led campaigns that were later recognised and celebrated at PMEA and Communiqué Awards.

“My time at Pfizer,” Thomas said, “required me to work across complex organisational structures and to understand what works, what doesn't and, most importantly, why that was the case.

“Success in that role was ultimately predicated on an ability to build, maintain and cultivate effective relationships based on trust and shared ownership with internal and external stakeholders alike.

“I believe those skills mean I will be able to make a real contribution to the Red Door Communications team and help develop their existing international offering still further”.

Thomas spent six years at Pfizer and prior to serving at the pharma company he worked at comms agencies Lowe Fusion and then Cohn and Wolfe.

Commenting on the appointment, Catherine Warne, head of Creston Health Group, said: “I have known Andrew for many years as a competitor and then a client. He is great fun, hugely well liked and respected in our industry and a proven influencer at a senior level.

“We are very excited that he is joining us and believe he is the ideal person to drive our international business."

7th September 2012

From: Marketing

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Say Communications

We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...